切换至 "中华医学电子期刊资源库"

中华腔镜泌尿外科杂志(电子版) ›› 2018, Vol. 12 ›› Issue (01) : 43 -46. doi: 10.3877/cma.j.issn.1674-3253.2018.01.012

所属专题: 文献

临床研究

膀胱扩张术治疗氯胺酮相关性膀胱挛缩的疗效观察
吴忠亮1, 陈征2, 张俊夫2, 徐晓龙3, 江东根2, 林佳钦4, 刘宏5, 狄金明2, 刘肖瑛6,()   
  1. 1. 437400 湖北,通城县人民医院泌尿外科
    2. 510630 广州,中山大学附属第三医院泌尿外科
    3. 523320 广东,东莞市第三人民医院泌尿外科
    4. 523110 广东,东莞市东华医院泌尿外科
    5. 441900 广东,东莞市长安医院泌尿外科
    6. 523080 广东,东莞康华医院检验科
  • 收稿日期:2017-02-22 出版日期:2018-02-01
  • 通信作者: 刘肖瑛
  • 基金资助:
    广州市科技计划项目(201709010038); 国家自然科学基金面上项目(81772752); 广东省科技计划项目(2017A020215122)

Cystectasia treatment of ketamine-associated urocystic contracture

Zhongliang Wu1, Zheng Chen2, Junfu Zhang2, Xiaolong Xu3, Donggen Jiang2, Jiaqin Lin4, Hong Liu5, Jinming Di2, Xiaoying Liu6,()   

  1. 1. Department of Urology, Tongcheng People's Hospital, Hubei 437400, China
    2. Department of Urology, the Third Affiliated Hospital of Sun Yet-Sen University, Guangzhou 510630, China
    3. Department of Urology, the Third People's Hospital of Dongguan, Guangdong 523320, China
    4. Department of Urology, Dongguan Donghua Hospital, Guangdong 523110, China
    5. Department of Urology, Chang'an Hospital of Dongguan, Guangdong 441900, China
    6. Department of Clinical Laboratory, Dongguan Kanghua hospital, Guangdong 523080, China
  • Received:2017-02-22 Published:2018-02-01
  • Corresponding author: Xiaoying Liu
  • About author:
    Corresponding author: Liu Xiaoying, Email:
引用本文:

吴忠亮, 陈征, 张俊夫, 徐晓龙, 江东根, 林佳钦, 刘宏, 狄金明, 刘肖瑛. 膀胱扩张术治疗氯胺酮相关性膀胱挛缩的疗效观察[J]. 中华腔镜泌尿外科杂志(电子版), 2018, 12(01): 43-46.

Zhongliang Wu, Zheng Chen, Junfu Zhang, Xiaolong Xu, Donggen Jiang, Jiaqin Lin, Hong Liu, Jinming Di, Xiaoying Liu. Cystectasia treatment of ketamine-associated urocystic contracture[J]. Chinese Journal of Endourology(Electronic Edition), 2018, 12(01): 43-46.

目的

探讨透明质酸钠平衡液膀胱扩张术治疗氯胺酮相关性膀胱挛缩的方法和疗效。

方法

2010年07月至2016年02月6家医院共收治滥用氯胺酮所致膀胱挛缩患者18例,男15例,女3例。患者戒断吸食氯胺酮,灌注0.09%透明质酸钠平衡液扩张膀胱,每周1次共3次,首次灌注2倍于术前膀胱容量的平衡液,随后灌注量每次递增100 ml。记录术前及3次扩张术后3、12个月时患者盆腔疼痛及尿频评分(PUF)、O'Leary-SantIC症状评分(ICSI)及问题评分(ICPI)、生活质量评分(QOL)和膀胱容量情况。

结果

18例患者均完成3次膀胱扩张术,术中无大出血、膀胱破裂等严重并发症。术后2例失访,2例8个月后复吸,14例完成最少12个月随访。该14例患者扩张术前及术后3、12个月时平均PUF分别为(20.4±3.6)、(11.5±3.1)和(13.2±3.3)分;ICSI分别为(13.6±2.8)、(7.7±2.3)和(8.2±2.5)分;ICPI分别为(10.6±2.6)、(7.3±2.1)和(7.7±2.5)分;QOL分别为(6.0±0)、(2.1±0.5)和(2.7±0.8)分;膀胱容量分别为(83±27)ml、(234±56)ml和(228±52)ml,所有指标术后与术前比较差异均有统计学意义(P<0.05)。

结论

透明质酸钠平衡液膀胱扩张术治疗氯胺酮相关性膀胱挛缩安全有效,手术操作简单,耐受性好。

Objective

To study the methods and efficiency of cystectasia in the treatment of ketamine-associated urocystic contracture.

Methods

Eighteen cases including 15 males and 3 females from 6 hospitals with ketamine-associated urocystic contracture from 2010 July to 2016 February were selected and analyzed. All patients were with drawal from ketamine and treated by weekly cystectasia with 0.09% sodium hyaluronate balance solution 3 times. Two times the preoperative bladder capacity balance solution was instilled in the cystoscope under direct vision for the first time, followed by an increase of 100 ml each time through urinary catheter. The Pelvic Pain and Urgency/Frequency symptom score (PUF), O'Leary-Sant IC Symptom Index (ICSI) and IC Problem Index (ICPI), QOL score and bladder capacity were recorded before the surgery, and during three and twelve months follow-up after the third expansion.

Results

All 18 patients were treated by cystectasia 3 times without significant complications such as intraoperative bleeding and bladder rupture. Two cases were lost after surgery. Two cases took ketamine again after 8 months. Fourteen cases were followed up at least 12 months. The mean PUF before the surgery, and three and twelve months follow-up after the third expansion were (20.4±3.6), (11.5±3.1) and (13.2±3.3) respectivly. The mean ICSI were (13.6±2.8), (7.7±2.3) and (8.2±2.5) respectivly. The mean ICPI were (10.6±2.6), (7.3±2.1) and (7.7±2.5) respectivly. The mean QOL score were (6.0±0), (2.1±0.5) and (2.7±0.8) respectivly. The mean bladder capacity were (83±27) ml, (234±56) ml and (228±52) ml respectivly. All postoperative indicators showed significant differences compared to the preoperative indicators.

Conclusions

Cystectasia with sodium hyaluronate balance solution is an effective way in the treatment of ketamine-associated urocystic contracture and the surgery is easy to perform and well tolerated.

图1 术前及3次扩张术后3个月的超声及CT对比图
表1 术前及3次扩张术后3、12个月时相关指标的比较(±s
[1]
Becerra L, Schwartzman RJ, Kiefer RT, et al. CNS measures of pain responses Pre- and Post-anesthetic ketamine in a patient with complex regional pain syndrome[J]. Pain Med, 2015, 16(12): 2368-2385.
[2]
Kidger E, Stahlschmidt J, Garthwaite M, et al. A rare urachal cyst in a case of ketamine-induced cystitis provides mechanistic insights[J]. Urology, 2016, 90: 223. e1-7.
[3]
Craven R. Ketamine[J]. Anaesthesia, 2007, 62(Suppl 1): 48-53.
[4]
Wai MS, Luan P, Jiang Y, et al. Long term ketamine and ketamine plus alcohol toxicity-what can we learn from animal models?[J]. Mini Rev Med Chem, 2013, 13(2): 273-279.
[5]
Oxley JD, Cottrell AM, Adams S, et al. Ketamine cystitis as a mimic of carcinoma in situ[J]. Histopathology, 2009, 55(6): 705-708.
[6]
方烈奎, 张泽键. 乙状结肠膀胱扩大成形术治疗氯胺酮所致膀胱挛缩[J]. 中华泌尿外科杂志, 2010, 31(7): 471-474.
[7]
McGinn KA, Bishop L, Sarwal A. Use of Ketamine in barbiturate coma for status epilepticus[J]. Clin Neuropharmacol, 2016, 39(1): 62-5.
[8]
李文君, 聂鹏. 氯胺酮及其代谢物的检验方法[J]. 现代仪器, 2008, 14(6): 1-4.
[9]
Chu PS, Ma WK, Wong SC,et al. The destruction of the lower urinary tract by ketamine abuse: a new syndrome?[J]. BJU Int, 2008, 102(11): 1616-1622.
[10]
Lai Y, Wu S, Ni L, et al.Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity[J]. Urol Int, 2012,89(1): 93-96.
[11]
吴芃, 赵洁, 高利生, 等. 氯胺酮相关性泌尿系统损害的影像学表现[J]. 南方医科大学学报, 2012, 32(8): 1143-1147.
[12]
Mason K, Cottrell AM, Corrigan AG, et al. Ketamine-associated lower urinary tract destruction: a new radiological challenge[J]. Clin Radiol, 2010, 65(10): 795-800.
[13]
易小春, 吴天鹏. 氯胺酮相关性泌尿系统损害研究进展[J]. 临床泌尿外科杂志, 2012, 27(6): 477-480.
[14]
Ng CM, Ma WK, To KC, et al. The chinese version of the pelvic pain and urgency/frequency symptom scale: a useful assessment tool for street-ketamine abusers with lower urinary tract symptoms[J]. Hong Kong Med J, 2012, 18(2): 123-130.
[15]
王宇雄, 刘春晓, 姜成龙, 等. 膀胱水扩术在大鼠氯胺酮性膀胱炎治疗中的应用效果观察[J]. 山东医药, 2013, 53(34): 21-23.
[16]
温世和, 陈剑平, 欧阳少青, 等. 膀胱水扩张联合灌注透明质酸钠治疗间质性膀胱炎的临床分析[J/CD]. 中华腔镜泌尿外科杂志(电子版), 2011, 5(3): 228-230.
[17]
Bao JM, Tan WL, Wang BW, et al. Transurethral front-firing Greenlight bladder autoaugmentation for bladder contracture: technique and clinical outcomes[J]. Int Urol Nephrol, 2016, 48(4): 475-480.
[18]
凌青, 王涛, 余虓, 等. 钬激光放射状膀胱切开术在治疗氯胺酮性膀胱炎中的作用[J]. 临床泌尿外科杂志, 2016, 31(5): 459-461.
[19]
Grégoire MC, MacLellan DL, Finley GA. A pediatric case of ketamine-associated cystitis[J].Urology, 2008, 71(6): 1232-1233.
[1] 杨姣, 王玲, 古兰, 安慎通, 胡大海, 韩军涛. 对艾司氯胺酮在烧伤后瘢痕手术患儿静脉穿刺中的应用效果观察[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 210-216.
[2] 杨姣, 王玲, 李娜, 陈丹丹, 胡大海, 韩军涛. 艾司氯胺酮复合麻醉在小儿瘢痕非插管全身麻醉患者超脉冲点阵二氧化碳激光治疗术中的应用及效果观察[J]. 中华损伤与修复杂志(电子版), 2022, 17(02): 119-125.
[3] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[4] 倪永梁, 王海新, 焦守镔, 杨义, 周强, 刘希高, 史本康. 膀胱灌注透明质酸钠联合膀胱区极超短波照射在非细菌性膀胱炎中的疗效研究[J]. 中华腔镜泌尿外科杂志(电子版), 2018, 12(05): 318-323.
[5] 高勤, 刘琪琳, 左友波. 超声引导下腹横平面阻滞联合氯胺酮麻醉与单纯氯胺酮麻醉用于小儿腹股沟疝手术的临床效果[J]. 中华疝和腹壁外科杂志(电子版), 2022, 16(02): 180-183.
[6] 刘光, 王会瑟. 氯胺酮静脉全身麻醉复合罗哌卡因骶管阻滞对腹股沟疝患儿术中应激反应的影响[J]. 中华疝和腹壁外科杂志(电子版), 2019, 13(03): 226-230.
[7] 吴一帆, 魏磊, 苏惠斌, 杨芬. 小剂量艾司氯胺酮对肺癌胸腔镜手术后抑郁及功能恢复的影响[J]. 中华肺部疾病杂志(电子版), 2022, 15(06): 856-858.
[8] 马聪, 李雪靖, 郑晓佐, 张晓阳, 段坤峰, 刘国强, 郄素会. 关节腔内注射富血小板血浆与透明质酸钠治疗Ⅰ-Ⅲ期膝骨关节炎的对比研究[J]. 中华老年骨科与康复电子杂志, 2023, 09(05): 282-288.
[9] 焦递进, 杨杰, 聂士超, 马旭, 王译晗, 王佳媛, 刘素媛, 邬波. 曲安奈德联合透明质酸钠治疗膝关节骨性关节炎的Meta分析[J]. 中华老年骨科与康复电子杂志, 2019, 05(06): 348-358.
[10] 黄泽辉, 梁杰贤, 曾伟. 右美托咪定联合艾司氯胺酮在小儿无痛胃镜检查中的应用研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 510-513.
[11] 林邹卿, 徐晓燕, 曹磊明, 王志强, 王国强, 张凯. S-氯胺酮治疗重度抑郁症疗效、安全性观察及机制讨论[J]. 中华临床医师杂志(电子版), 2022, 16(08): 719-724.
[12] 李申, 李洁, 田红军, Leemon Albert, Martin Walter, 禚传君. 治疗时间对氯胺酮抗抑郁作用影响的研究概况及未来展望[J]. 中华诊断学电子杂志, 2018, 06(03): 151-156.
阅读次数
全文


摘要